Deenova Sold by H.I.G. Capital to Equiter Infrastructure II and Amundi PE

H.I.G. Capital, a significant player in global alternative investments, has entered into a definitive agreement to sell Deenova S.r.l., its portfolio company and a leader in the traceability of drugs and medical devices within European hospitals, to Equiter Infrastructure II, managed by Ersel Asset Management SGR, and Amundi Private Equity Italia, in conjunction with Deenova's founder Sergio Giglio. This transaction, pending customary regulatory approvals, marks an important strategic move for both H.I.G. and Deenova, which has showcased substantial international growth under H.I.G.'s guidance. Deenova's pioneering systems are operational in approximately 100 hospitals across Europe, reflecting its established position in the healthcare sector. H.I.G.'s sale underscores the firm's ability to enhance company value and strategically position firms for continued growth. The transaction is set against the backdrop of H.I.G.'s broader investment strategy that leverages a combination of buyouts, recapitalizations, carve-outs, and debt investments across various market sectors. Through this exit, H.I.G. maintains its strong portfolio, reinforcing its effective investment methodologies.